ESPR - Esperion Therapeutics Inc Earnings

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: SUPN ALKS PRGO BHC AMRX INDV LNTH TEVA VTRS HRMY

Scroll to Statements

Index	-
Market Cap	818.53M
Enterprise Value	1.21B
Income	-7.42M
Sales	418.24M
Book/sh	-1.20
Cash/sh	0.61
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	294
IPO	Jun 26, 2013

P/E	-
Forward P/E	10.48
PEG	-
P/S	1.96
P/B	-
P/C	5.24
P/FCF	-
EV/EBITDA	15.90
EV/Sales	2.88
Quick Ratio	1.18
Current Ratio	1.53
Debt/Eq	-
LT Debt/Eq	-
Option/Short	Yes / No

EPS (ttm)	-0.10
EPS next Y	0.30
EPS next Q	-0.03
EPS this Y	-59.09%
EPS next Y	273.33%
EPS next 5Y	-
EPS past 3/5Y	68.58% 53.87%
Sales past 3/5Y	74.80% 12.12%
EPS Y/Y TTM	92.51%
Sales Y/Y TTM	61.13%
EPS Q/Q	51.43%
Sales Q/Q	23.25%
Earnings	May 08 BMO
EPS/Sales Surpr.	-169.54% -5.23%

Insider Own	-
Insider Trans	-
Inst Own	71.59%
Inst Trans	9.55%
ROA	-1.89%
ROE	-
ROIC	-4.84%
Gross Margin	68.38%
Oper. Margin	18.12%
Profit Margin	-1.77%
SMA20	0.60%
SMA50	2.72%
SMA200	4.10%
Trades

Shs Outstand	257.40M
Shs Float	242.03M
Short Float	7.19%
Short Ratio	1.13
Short Interest	17.40M
52W High	4.18 -23.83%
52W Low	1.10 189.09%
Volatility	0.63% 0.57%
ATR (14)	0.02
RSI (14)	64.75
Beta	1.09
Rel Volume	0.00
Avg Volume	15.45M
Volume	0

Perf Week	-
Perf Month	0.95%
Perf Quarter	66.49%
Perf Half Y	0.32%
Perf YTD	-14.05%
Perf Year	156.45%
Perf 3Y	97.52%
Perf 5Y	-83.50%
Perf 10Y	-71.58%
Recom	3.25
Target Price	3.16
Prev Close	3.18
Price	3.18
Change	0.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)